Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. (Record no. 30274482)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02145 a2200589 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518065813.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202012s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2055-6845 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1093/ehjcvp/pvz061 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Nicolau, André M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20201201 |
245 00 - TITLE STATEMENT | |
Title | Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | European heart journal. Cardiovascular pharmacotherapy |
Date of publication, distribution, etc. | 07 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 167-175 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anticoagulants |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Atrial Fibrillation |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Comorbidity |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Factor Xa Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Assessment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stroke |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Thiazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Thromboembolism |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Warfarin |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Corbalan, Ramon |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nicolau, Jose C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ruff, Christian T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zierhut, Wolfgang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kerschnitzki, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Duris, Tibor |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Juul-Möller, Steen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Voitk, Juri |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Trevisan, Marco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nordio, Francesco |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Antman, Elliott M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Giugliano, Robert P |
773 0# - HOST ITEM ENTRY | |
Title | European heart journal. Cardiovascular pharmacotherapy |
Related parts | vol. 6 |
-- | no. 3 |
-- | p. 167-175 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1093/ehjcvp/pvz061">https://doi.org/10.1093/ehjcvp/pvz061</a> |
Public note | Available from publisher's website |
No items available.